HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Humacyte to Participate at Upcoming Investor Conferences in May
Humacyte First Quarter 2024 Financial Results and Business Update [Yahoo! Finance]
Humacyte First Quarter 2024 Financial Results and Business Update
Form 10-Q Humacyte, Inc. For: Mar 31
Form 8-K Humacyte, Inc. For: May 10
Form DEFA14A Humacyte, Inc.
Form DEF 14A Humacyte, Inc. For: Jun 11
Form S-8 Humacyte, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.